P. Kim

发表

Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer.

C. Sander, B. Taylor, N. Schultz, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma.

S. Gabriel, G. Getz, P. Kantoff, 2014, Cancer discovery.

Bladder biopsy of normal-appearing mucosa is not helpful in patients with unexplained positive cytology after nonmuscle invasive bladder cancer.

P. Kim, H. Herr, M. O'shaughnessy, 2015, The Journal of urology.

The role of PTEN tumor suppressor pathway staining in carcinoma in situ of the bladder.

H. Al-Ahmadie, B. Bochner, P. Kim, 2014, Urologic oncology.

The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer

B. Bochner, D. Bajorin, P. Kim, 2014, World Journal of Urology.

A phase 2 trial of buparlisib in patients with platinum‐resistant metastatic urothelial carcinoma

M. Berger, E. V. Van Allen, I. Ostrovnaya, 2020, Cancer.

Outcomes in patients undergoing nephrectomy for renal cancer on chronic anticoagulation therapy.

P. Russo, A. Hakimi, P. Kim, 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Mesothelioma of tunica vaginalis testis: A case report of two subtypes

P. Kim, B. Lowenthal, N. Rocco, 2020, Journal of Clinical Urology.

Factors that affect proportional glomerular filtration rate after minimally invasive partial nephrectomy.

R. Ghavamian, A. Hakimi, J. Coleman, 2013, Journal of endourology.

Targeted sequencing of upper tract urothelial carcinoma.

M. Berger, J. Coleman, G. Iyer, 2014 .

Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopy

A. Hakimi, D. Sjoberg, P. Kim, 2014, BJU international.

Preoperative serum albumin is associated with mortality and complications after radical cystectomy

P. Kim, T. Garg, H. Herr, 2014, BJU international.

The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guérin.

A. Hakimi, P. Kim, J. Sfakianos, 2014, The Journal of urology.

Branched evolution and intratumor heterogeneity of urothelial carcinoma of the bladder.

M. Berger, G. Iyer, H. Al-Ahmadie, 2014 .

Midline extraperitoneal approach for retroperitoneal lymph node dissection for testicular germ cell tumor.

P. Kim, S. Daneshmand, H. Djaladat, 2012, Urology.

Genomic Characterization of Upper Tract Urothelial Carcinoma.

N. Schultz, M. Berger, V. Reuter, 2015, European urology.

Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder.

N. Schultz, M. Berger, V. Reuter, 2015, European urology.

AXIN2 expression predicts prostate cancer recurrence and regulates invasion and tumor growth

S. Groshen, M. Li, E. Davicioni, 2015, The Prostate.

An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma.

C. Sander, P. Laird, N. Schultz, 2013, Journal of the National Cancer Institute.

The impact of metformin use on recurrence and cancer-specific survival in clinically localized high-risk renal cell carcinoma.

P. Russo, A. Hakimi, D. Sjoberg, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Impact of recurrent copy number alterations and cancer gene mutations on the predictive accuracy of prognostic models in clear cell renal cell carcinoma.

G. Ciriello, R. Motzer, P. Russo, 2014, The Journal of urology.

Disparities in Stage at Diagnosis in an Equal-access Integrated Delivery System: A Retrospective Cohort Study of 7244 Patients With Bladder Cancer.

T. Luong, P. Kim, K. Danforth, 2019, Clinical genitourinary cancer.

Germline single nucleotide polymorphisms associated with response of urothelial carcinoma to platinum-based therapy: the role of the host.

K. Offit, I. Ostrovnaya, G. Iyer, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Definitive pathology at radical prostatectomy is commonly favorable in men following initial active surveillance.

P. Scardino, J. Eastham, P. Kim, 2014, European urology.

Trends in the use of incontinence procedures after radical prostatectomy: a population based analysis.

Coral L. Atoria, E. Elkin, J. Eastham, 2012, The Journal of urology.

Current Trends in Pediatric Minimally Invasive Urologic Surgery

P. Kim, C. Koh, Dennis J. Lee, 2010, Korean journal of urology.

Care Quality and Variability in the Use of Intravesical Therapy for Initial Treatment of Non-Muscle Invasive Bladder Cancer within a Large, Diverse Integrated Delivery System.

T. Luong, P. Kim, K. Danforth, 2019, Urology.

Health Services Research Care Quality and Variability in the Use of Intravesical Therapy for Initial Treatment of Nonmuscle Invasive Bladder Cancer Within a Large, Diverse Integrated Delivery System

T. Luong, P. Kim, K. Danforth, 2019 .

MP77-14 CAN PRE-OPERATIVE CT IDENTIFY POSITIVE LYMPH NODES IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA?

J. Coleman, P. Kim, J. Sfakianos, 2014 .

Early comparison of nephrectomy options in children (open, transperitoneal laparoscopic, laparo‐endoscopic single site (LESS), and robotic surgery)

P. Kim, I. Gill, M. Desai, 2012, BJU international.

Trends in partial and radical nephrectomy: an analysis of case logs from certifying urologists.

P. Russo, P. Kim, B. Ehdaie, 2013, The Journal of urology.

Association of somatic ERCC2 mutations with cisplatin sensitivity in muscle-invasive urothelial carcinoma.

S. Gabriel, G. Getz, P. Kantoff, 2014 .

Outcomes of patients with clinical CIS-only disease treated with radical cystectomy

P. Kim, J. Stein, D. Skinner, 2009, World Journal of Urology.

Multicenter evaluation of the role of UroVysion FISH assay in surveillance of patients with bladder cancer: does FISH positivity anticipate recurrence?

J. Rao, C. Seideman, Y. Lotan, 2015, World Journal of Urology.

Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy.

N. Socci, B. Taylor, N. Schultz, 2014, Cancer discovery.

Gemcitabine-cisplatin (GC) plus radical cystectomy-pelvic lymph node dissection (RC-PLND) for patients (pts) with muscle-invasive bladder cancer (MIBC): Assessing impacts of neoadjuvant chemotherapy (NAC) and the PLND.

I. Ostrovnaya, B. Bochner, D. Bajorin, 2014 .

Age is Associated with Upgrading at Confirmatory Biopsy among Men with Prostate Cancer Treated with Active Surveillance.

J. Eastham, H. Vargas, D. Sjoberg, 2015, The Journal of urology.

Predicting progression in patients followed with active surveillance for low-risk prostate cancer.

M. Kattan, V. Laudone, P. Scardino, 2014 .

Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma.

S. Gabriel, G. Getz, P. Kantoff, 2014, Cancer discovery.

Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy.

N. Socci, B. Taylor, N. Schultz, 2014, Cancer discovery.